13F Pro quality score
Rank #2,680 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from IMMUTEP Ltd's annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2026 | 20-F | $24.2M | $-79.3M | — |
| FY 2025 | 20-F | $10.3M | $-61.4M | — |
| FY 2024 | 20-F | $7.8M | $-42.7M | — |
| FY 2023 | 20-F | $5.2M | $-39.9M | — |
| FY 2022 | 20-F | $6.8M | $-32.2M | — |
| FY 2021 | 20-F | $4.0M | $-29.9M | — |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
IMMUTEP Ltd (IMMP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IMMP at 23.7/100 on a composite quality score built from its SEC filings, placing it at rank #2,680 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2026), IMMUTEP Ltd reports quarterly revenue of $24.2M, net income of $-79.3M, free cash flow of $-55.6M. Top institutional holders of IMMP by reported 13-F value include BlackRock, Vanguard Personalized Indexing Management, MARSHALL WACE, LLP, based on the most recent SEC filings. IMMP trades on the Nasdaq exchange and files with the SEC under CIK 1506184. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IMMP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for IMMUTEP Ltd directly from SEC EDGAR.